94 related articles for article (PubMed ID: 23766100)
1. Incurable recurrences in patients with oropharyngeal and hypopharyngeal carcinomas.
Wiegand S; Zimmermann AP; Müller HH; Werner JA; Sesterhenn AM
Head Neck; 2014 Feb; 36(2):231-4. PubMed ID: 23766100
[TBL] [Abstract][Full Text] [Related]
2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
3. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
[TBL] [Abstract][Full Text] [Related]
4. Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.
Lehnerdt GF; Franz P; Zaqoul A; Schmitz KJ; Grehl S; Lang S; Schmid KW; Siffert W; Jahnke K; Frey UH
Clin Cancer Res; 2008 Mar; 14(6):1753-8. PubMed ID: 18347176
[TBL] [Abstract][Full Text] [Related]
5. [Distant metastasis and incidence of second carcinomas in patients with oropharyngeal and hypopharyngeal carcinomas].
Mohadjer C; Dietz A; Maier H; Weidauer H
HNO; 1996 Mar; 44(3):134-9. PubMed ID: 8641899
[TBL] [Abstract][Full Text] [Related]
6. Cancer of the oro- and hypopharynx - when to expect recurrences?
Sesterhenn AM; Muller HH; Wiegand S; Teymoortash A; Folz BJ; Werner JA
Acta Otolaryngol; 2008 Aug; 128(8):925-9. PubMed ID: 18612853
[TBL] [Abstract][Full Text] [Related]
7. Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
Kawakita D; Masui T; Hanai N; Ozawa T; Hirakawa H; Terada A; Nishio M; Hosoi H; Hasegawa Y
Acta Otolaryngol; 2013 May; 133(5):523-30. PubMed ID: 23679812
[TBL] [Abstract][Full Text] [Related]
8. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
[TBL] [Abstract][Full Text] [Related]
9. [Dynamics and significance of immunoglobulin E (IgE) as an immunological parameter in squamous cell carcinomas of the oral cavity and pharynx].
Mayer BA; Enzmann H
Laryngol Rhinol Otol (Stuttg); 1987 Jun; 66(6):316-9. PubMed ID: 3626713
[TBL] [Abstract][Full Text] [Related]
10. Salvage surgery for recurrent oropharyngeal cancer: post-operative oncologic and functional outcomes.
Culié D; Benezery K; Chamorey E; Ettaiche M; Fernandez J; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Sudaka A; Haudebourg J; Demard F; Santini J; Peyrade F; Dassonville O; Bozec A
Acta Otolaryngol; 2015; 135(12):1323-9. PubMed ID: 26223741
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of the oropharynx and hypopharynx.
Lin DT; Cohen SM; Coppit GL; Burkey BB
Otolaryngol Clin North Am; 2005 Feb; 38(1):59-74, viii. PubMed ID: 15649499
[TBL] [Abstract][Full Text] [Related]
12. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer.
Beckmann GK; Hoppe F; Pfreundner L; Flentje MP
Head Neck; 2005 Jan; 27(1):36-43. PubMed ID: 15459918
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
Doweck I; Robbins KT; Samant S; Vieira F
World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
[TBL] [Abstract][Full Text] [Related]
14. Salvage treatment for recurrent oropharyngeal squamous cell carcinoma.
Röösli C; Studer G; Stoeckli SJ
Head Neck; 2010 Aug; 32(8):989-96. PubMed ID: 19953618
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoma of the mouth and pharynx--better prognosis by an early diagnosis!].
Fischer CA; Gerstner AO; Bootz F
Ther Umsch; 2004 May; 61(5):329-33. PubMed ID: 15195719
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of the extent of advanced oropharyngeal and hypopharyngeal cancers by narrow band imaging with magnifying endoscopy.
Matsuba H; Katada C; Masaki T; Nakayama M; Okamoto T; Hanaoka N; Tanabe S; Koizumi W; Okamoto M; Muto M
Laryngoscope; 2011 Apr; 121(4):753-9. PubMed ID: 21298647
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Ng SH; Lin CY; Chan SC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Huang SF; Lin YC; Wang JJ
PLoS One; 2013; 8(8):e72230. PubMed ID: 23951300
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites.
Muto M; Nakane M; Katada C; Sano Y; Ohtsu A; Esumi H; Ebihara S; Yoshida S
Cancer; 2004 Sep; 101(6):1375-81. PubMed ID: 15368325
[TBL] [Abstract][Full Text] [Related]
20. Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx.
Schuller DE; Grecula JC; Agrawal A; Rhoades CA; Orr DA; Young DC; Malone JP; Merz M
Cancer; 2002 Jun; 94(12):3169-78. PubMed ID: 12115349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
